Grandfield & Dodd, LLC
- SEC CIK
- 0001308016
- Latest filing
- Aug 7, 2026
BIIB holding history
Biogen Inc. in every 13F filed by Grandfield & Dodd, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BIIB overviewAll 13F holders of BIIBFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −1,261−100.0% | Sold out | Holders |
| Q3 2024 | 1,261 | $244.4K | <0.1% | +62+5.2% | Added | Holders |
| Q2 2024 | 1,199 | $278.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 1,199 | $258.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 1,199 | $310.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 1,199 | $308.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 1,199 | $341.5K | <0.1% | −160−11.8% | Reduced | Holders |
| Q1 2023 | 1,359 | $377.8K | <0.1% | +1,359 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −823−100.0% | Sold out | Holders |
| Q3 2021 | 823 | $230.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 823 | $280.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 823 | $230.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.